litlas
ログインアカウント作成

Ursula A. Matulonis

1992–2025 年に発表

別表記
Ursula A Matulonis
213
論文数
39,525
被引用数
104
h 指数
207
i10 指数

被引用数

Ursula A. Matulonis の年別被引用数1945 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 10 件1995 年: 被引用 13 件1996 年: 被引用 12 件1997 年: 被引用 12 件1998 年: 被引用 10 件1999 年: 被引用 8 件2000 年: 被引用 8 件2001 年: 被引用 10 件2002 年: 被引用 27 件2003 年: 被引用 39 件2004 年: 被引用 41 件2005 年: 被引用 28 件2006 年: 被引用 34 件2007 年: 被引用 34 件2008 年: 被引用 64 件2009 年: 被引用 58 件2010 年: 被引用 101 件2011 年: 被引用 167 件2012 年: 被引用 173 件2013 年: 被引用 235 件2014 年: 被引用 273 件2015 年: 被引用 295 件2016 年: 被引用 413 件2017 年: 被引用 485 件2018 年: 被引用 486 件2019 年: 被引用 1,659 件2020 年: 被引用 2,077 件2021 年: 被引用 2,118 件2022 年: 被引用 1,799 件2023 年: 被引用 1,500 件2024 年: 被引用 2,100 件2025 年: 被引用 1,022 件2026 年: 被引用 18 件1946〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,610 件、この内訳の 27.8%中国: 引用元論文 2,100 件、この内訳の 12.6%イギリス: 引用元論文 1,128 件、この内訳の 6.8%イタリア: 引用元論文 837 件、この内訳の 5%カナダ: 引用元論文 688 件、この内訳の 4.1%ドイツ: 引用元論文 641 件、この内訳の 3.9%フランス: 引用元論文 613 件、この内訳の 3.7%スペイン: 引用元論文 538 件、この内訳の 3.2%オーストラリア: 引用元論文 479 件、この内訳の 2.9%日本: 引用元論文 449 件、この内訳の 2.7%オランダ: 引用元論文 396 件、この内訳の 2.4%スイス: 引用元論文 303 件、この内訳の 1.8%
0%27.8%その他 23.1%

機関

分野

  • Medicine61.7%
  • Biochemistry, Genetics and Molecular Biology27.5%
  • Immunology and Microbiology5.9%
  • Materials Science1.1%
  • Engineering0.9%
  • Computer Science0.5%
  • その他2.4%

トピック

  • PARP inhibition in cancer therapy8.1%
  • Ovarian cancer diagnosis and treatment6.8%
  • Cancer Immunotherapy and Biomarkers3.8%
  • DNA Repair Mechanisms3.7%
  • Cancer Genomics and Diagnostics2.8%
  • Endometrial and Cervical Cancer Treatments2.2%
  • その他72.6%

共著者

全論文

検索で開く
  1. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

    著者: Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt, Amit M. Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A. Ledermann, Domenica Lorusso, Ignace Vergote, Noa Ben-Baruch, Christian Marth, Radosław Mądry, René dePont Christensen, Jonathan S. Berek, Anne Dørum, Anna V. Tinker, Andreas du Bois, Antonio González-Martı́n, Philippe Follana, Benedict B. Benigno, Per Rosenberg, Lucy Gilbert, B.J. Rimel, Joseph Buscema, John Balser, Shefali Agarwal, Ursula A. Matulonis - New England Journal of Medicine 2016 被引用: 2,458

  2. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors

    著者: Michal Slyper, Caroline Porter, Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro, Christopher S. Smillie, Gabriela Smith-Rosario, Jingyi Wu, Danielle Dionne, Sébastien Vigneau, Judit Jané‐Valbuena, Timothy L. Tickle, Sara Napolitano, Mei-Ju Su, Anand G. Patel, Åsa Karlström, Simon Gritsch, Masashi Nomura, Avinash Waghray, Satyen H. Gohil, Alexander M. Tsankov, Livnat Jerby‐Arnon, Ofir Cohen, Johanna Klughammer, Yanay Rosen, Joshua Gould, Lan Nguyễn, Matan Hofree, Peter J. Tramontozzi, Bo Li, Catherine J. Wu, Benjamin Izar, Rizwan Haq, F. Stephen Hodi, Charles H. Yoon, Aaron N. Hata, Suzanne J. Baker, Mario L. Suvà, Raphael Bueno, Elizabeth H. Stover, Michael R. Clay, Michael A. Dyer, Natalie B. Collins, Ursula A. Matulonis, Nikhil Wagle, Bruce E. Johnson, Asaf Rotem, Orit Rozenblatt–Rosen, Aviv Regev - Nature Medicine 2020 被引用: 805

  3. Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study

    著者: Ursula A. Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo, Philipp Harter, Conleth G. Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L. Coleman - Journal of Clinical Oncology 2023 被引用: 372

  4. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

    著者: Ursula A. Matulonis, Ronnie Shapira‐Frommer, Alessandro D. Santin, Alla Lisyanskaya, Sandro Pignata, Ignace Vergote, Francesco Raspagliesi, Gabe S. Sonke, Michael J. Birrer, Diane Provencher, Jalid Sehouli, Nicoletta Colombo, Antonio González-Martı́n, Ana Oaknin, Petronella B. Ottevanger, Vilius Rudaitis, Kianoosh Katchar, Huita Wu, Stephen J. O’Keefe, Jane Ruman, Jonathan A. Ledermann - Annals of Oncology 2019 被引用: 840

  5. Ovarian cancer

    著者: Ursula A. Matulonis, Anil K. Sood, Lesley Fallowfield, Brooke E. Howitt, Jalid Sehouli, Beth Y. Karlan - Nature Reviews Disease Primers 2016 被引用: 1,291

  6. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer

    著者: Qiwei Wang, Johann S. Bergholz, Liya Ding, Ziying Lin, Sheheryar Kabraji, Melissa E. Hughes, Xiadi He, Shaozhen Xie, Tao Jiang, Weihua Wang, Jason J. Zoeller, Hye‐Jung Kim, Thomas M. Roberts, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis, Deborah Dillon, Eric P. Winer, Nancy U. Lin, Jean J. Zhao - Nature Communications 2022 被引用: 247

  7. A single-cell landscape of high-grade serous ovarian cancer

    著者: Benjamin Izar, Itay Tirosh, Elizabeth H. Stover, Isaac Wakiro, Michael S. Cuoco, Idan Alter, Christopher Rodman, Rachel Leeson, Mei-Ju Su, Parin Shah, Marcin Iwanicki, Sarah R. Walker, Abhay Kanodia, Johannes C. Melms, Shaolin Mei, Jia‐Ren Lin, Caroline Porter, Michal Slyper, Julia Waldman, Livnat Jerby‐Arnon, Orr Ashenberg, Titus J. Brinker, Caitlin E. Mills, Meri Rogava, Sébastien Vigneau, Peter K. Sorger, Levi A. Garraway, Panagiotis A. Konstantinopoulos, Joyce F. Liu, Ursula A. Matulonis, Bruce E. Johnson, Orit Rozenblatt–Rosen, Asaf Rotem, Aviv Regev - Nature Medicine 2020 被引用: 522

  8. Clinical and translational advances in ovarian cancer therapy

    著者: Panagiotis A. Konstantinopoulos, Ursula A. Matulonis - Nature Cancer 2023 被引用: 361

  9. Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma

    著者: Panagiotis A. Konstantinopoulos, Steven Waggoner, Gregory A. Vidal, Monica Mita, John W. Moroney, Robert W. Holloway, Linda Van Le, Jasgit C. Sachdev, Eloise Chapman‐Davis, Gerardo Colón‐Otero, Richard T. Penson, Ursula A. Matulonis, Young Bae Kim, Kathleen N. Moore, Elizabeth M. Swisher, Anniina Färkkilä, Alan D. D’Andrea, Erica Stringer-Reasor, Jing Wang, Nathan Buerstatte, Sujata Arora, Julie R. Graham, Dmitri Bobilev, Bruce J. Dezube, Pamela N. Münster - JAMA Oncology 2019 被引用: 560

  10. Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

    著者: Jonathan A. Ledermann, Philipp Harter, Charlie Gourley, Michael Friedländer, Ignace Vergote, Gordon Rustin, Clare L. Scott, Werner Meier, Ronnie Shapira‐Frommer, Tamar Safra, Daniela Matei, Euan Macpherson, Claire Watkins, James Carmichael, Ursula A. Matulonis - New England Journal of Medicine 2012 被引用: 1,891

  11. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer

    著者: Liya Ding, Hye‐Jung Kim, Qiwei Wang, Michael Kearns, Tao Jiang, Carolynn E. Ohlson, Ben B. Li, Shaozhen Xie, Joyce F. Liu, Elizabeth H. Stover, Brooke E. Howitt, Roderick T. Bronson, Suzan Lazo, Thomas M. Roberts, Gordon J. Freeman, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis, Jean J. Zhao - Cell Reports 2018 被引用: 571

  12. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

    著者: Jonathan A. Ledermann, Philipp Harter, Charlie Gourley, Michael Friedländer, Ignace Vergote, Gordon Rustin, Clare L. Scott, Werner Meier, Ronnie Shapira‐Frommer, Tamar Safra, Daniela Matei, Anitra Fielding, Stuart Spencer, Brian Dougherty, Maria Orr, Darren Hodgson, J. Carl Barrett, Ursula A. Matulonis - The Lancet Oncology 2014 被引用: 1,443

  13. Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

    著者: Sarah J. Hill, Brennan Decker, Emma A. Roberts, Neil S. Horowitz, Michael G. Muto, Michael J. Worley, Colleen M. Feltmate, Marisa R. Nucci, Elizabeth M. Swisher, Huy Nguyen, Chunyu Yang, Ryuji Morizane, Bose Kochupurakkal, T. Khanh, Panagiotis A. Konstantinopoulos, Joyce F. Liu, Joseph V. Bonventre, Ursula A. Matulonis, Geoffrey I. Shapiro, Ross S. Berkowitz, Christopher P. Crum, Alan D. D’Andrea - Cancer Discovery 2018 被引用: 457

  14. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

    著者: M. William Audeh, James Carmichael, Richard T. Penson, Michael Friedländer, Bethan Powell, Katherine M. Bell‐McGuinn, Clare L. Scott, Jeffrey N. Weitzel, Ana Oaknin, Niklas Loman, Karen H. Lu, Rita K. Schmutzler, Ursula A. Matulonis, Mark Wickens, Andrew Tutt - The Lancet 2010 被引用: 2,283

  15. Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

    著者: Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller, David S. Miller, Noelle Cloven, Gini F. Fleming, Andrea E. Wahner Hendrickson, Masoud Azodi, Paul DiSilvestro, Amit M. Oza, Mihaela Cristea, Jonathan S. Berek, John K. Chan, B.J. Rimel, Daniela Matei, Yong Li, Kaiming Sun, Katarina Luptakova, Ursula A. Matulonis, Bradley J. Monk - The Lancet Oncology 2019 被引用: 537

  16. Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer

    著者: Lucy Gilbert, Ana Oaknin, Ursula A. Matulonis, Gina Mantia-Smaldone, Peter Lim, Cesar M. Castro, Diane Provencher, Sanaz Memarzadeh, Michael Method, Jiuzhou Wang, Kathleen N. Moore, David M. O’Malley - Gynecologic Oncology 2023 被引用: 108

  17. Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

    著者: Daniela Matei, Virginia L. Filiaci, Marcus E. Randall, David G. Mutch, Margaret M. Steinhoff, Paul DiSilvestro, Katherine Moxley, Yong M. Kim, Matthew A. Powell, David M. O’Malley, Nick M. Spirtos, William Small, Krishnansu S. Tewari, William E. Richards, John Nakayama, Ursula A. Matulonis, Helen Huang, David S. Miller - New England Journal of Medicine 2019 被引用: 467

  18. Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

    著者: Brooke E. Howitt, Sachet A. Shukla, Lynette M. Sholl, Lauren L. Ritterhouse, Jaclyn C. Watkins, Scott J. Rodig, Elizabeth H. Stover, Kyle C. Strickland, Alan D. D’Andrea, Catherine J. Wu, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos - JAMA Oncology 2015 被引用: 685

  19. Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer

    著者: Anniina Färkkilä, D. Gulhan, Julia Casado, Connor A. Jacobson, Huy Nguyen, Bose Kochupurakkal, Zoltan Maliga, Clarence Yapp, Yu‐An Chen, Denis Schapiro, Yinghui Zhou, Julie R. Graham, Bruce J. Dezube, Pamela N. Münster, Sandro Santagata, Elizabeth Garcia, Scott J. Rodig, Ana Lako, Dipanjan Chowdhury, Geoffrey I. Shapiro, Ursula A. Matulonis, Peter J. Park, Sampsa Hautaniemi, Peter K. Sorger, Elizabeth M. Swisher, Alan D. D’Andrea, Panagiotis A. Konstantinopoulos - Nature Communications 2020 被引用: 341

  20. Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

    著者: Panagiotis A. Konstantinopoulos, Su-Chun Cheng, Andrea E. Wahner Hendrickson, Richard T. Penson, Susan Schumer, L. Austin Doyle, Elizabeth K. Lee, Elise C. Kohn, Linda Duska, Marta A. Crispens, Alexander Olawaiye, Ira Winer, Lisa Barroilhet, Siqing Fu, Michael McHale, Russell J. Schilder, Anniina Färkkilä, Dipanjan Chowdhury, Jennifer Curtis, Roxanne Quinn, Brittany Bowes, Alan D. D’Andrea, Geoffrey I. Shapiro, Ursula A. Matulonis - The Lancet Oncology 2020 被引用: 232

  21. Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

    著者: Changxin Wan, Matthew P. Keany, Han Dong, Linah Al-Alem, Unnati M. Pandya, Suzan Lazo, Karsten Boehnke, Katherine N. Lynch, Rui Xu, Dominique T. Zarrella, Shengqing Gu, Paloma Cejas, Klothilda Lim, Henry W. Long, Kevin M. Elias, Neil S. Horowitz, Colleen M. Feltmate, Michael G. Muto, Michael J. Worley, Ross S. Berkowitz, Ursula A. Matulonis, Marisa R. Nucci, Christopher P. Crum, Bo R. Rueda, Myles Brown, Xiaole Shirley Liu, Sarah J. Hill - Cancer Research 2020 被引用: 215

  22. Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma

    著者: Joyce F. Liu, Niya Xiong, Susana M. Campos, Alexi A. Wright, Carolyn Krasner, Susan Schumer, Neil S. Horowitz, Jennifer Veneris, Nabihah Tayob, Stephanie Morrissey, Gabriela West, Roxanne Quinn, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos - Journal of Clinical Oncology 2021 被引用: 195

  23. STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer

    著者: Liya Ding, Qiwei Wang, Antons Martincuks, Michael J. Kearns, Tao Jiang, Ziying Lin, Xin Cheng, Changli Qian, Shaozhen Xie, Hye‐Jung Kim, Inga-Maria Launonen, Anniina Färkkilä, Thomas M. Roberts, Gordon J. Freeman, Joyce F. Liu, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis, Hua Yu, Jean J Zhao - Journal for ImmunoTherapy of Cancer 2023 被引用: 92

  24. Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer

    著者: Joyce F. Liu, Christina I. Herold, Kathryn P. Gray, Richard T. Penson, Neil S. Horowitz, Panagiotis A. Konstantinopoulos, Cesar M. Castro, Sarah J. Hill, Jennifer Curtis, Weixiu Luo, Ursula A. Matulonis, Stephen A. Cannistra, Don S. Dizon - JAMA Oncology 2019 被引用: 227